PIDs Linked to PI3K research hub

Long-term Safety and Efficacy of Leniolisib in PIDs With Immune Dysregulation

This study is for people with certain immune conditions (PIDs) linked to a specific problem with their immune cells. It's an extension of a previous study testing a medicine called leniolisib. The main goal is to check its long-term safety and how well it works for these conditions.